Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

CoreRx Adds Investment to Expand Oral Dosage Form Capabilities

July 01, 2021 at 09:30 AM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Investment Will Enhance Development, Scale-up, and Tech Transfer Capabilities Across its US Sites

CLEARWATER, FLORIDA, UNITED STATES, July 1, 2021 /EINPresswire.com/ -- CoreRx, Inc. announced today that it is adding investment in formulation development and manufacturing equipment in both its Clearwater, Florida and San Rafael, California facilities.

Following on from the recently announced acquisition of Nucleo Life Sciences, this investment will harmonize equipment across both sites to enable the seamless transfer of technology for projects as they scale up from the San Rafael site to the Clearwater site. The investment includes increased dry granulation and spray-dried dispersion (SDD) capabilities.

CoreRx Chief Scientific Officer Mark Menning stated, “This investment allows us to continue to serve our customers with state-of-the-art equipment, including from well-known industry suppliers such as Gerteis, ProCepT, and GEA Group*. This investment furthers the integration of our operations and approach to product and process development from both of our facilities. The ultimate benefit is that these additions will streamline the path from early phase clinical development to commercial manufacturing for our clients.”

The company expects the equipment to be in place and validated by Q4 2021.

*Gerteis Maschinen and Processengineering AG (Jona, Switzerland), ProCepT, NV (Zele, Belgium) and GEA Group (Düsseldorf, Germany)

About CoreRx:
CoreRx is a Contract Development Manufacturing Organization (CDMO) with capabilities to support clinical and commercial manufacturing needs, offering state of the art facilities to support customers supply chain needs. Our integrated offerings provide comprehensive services for the development, manufacturing, and testing of solid, liquid and semi-solid dosage forms.

Keep on top of new developments at CoreRx by following www.linkedin.com/company/corerx-inc-more detailed information about the company can be found at www.corerxpharma.com.

Joanna Disley
CoreRx, Inc.
+1 727-259-6950
email us here

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article